Medication info

Zanqpro 150 mg Tablet (Ranitidine Hydrochloride)

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Ranitidine Hydrochloride›168mg / 1 tablet
Manufacturer / importer
Highple Life Sciences Co., Ltd.
Appearance
Cream to pale yellow round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 201906561 · Approved 2019.09.19

This product's status changed to Approval withdrawn on 2024.03.28. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (such as ulcers), improvement of gastric mucosal lesions, and prevention of Mendelson's syndrome
Who takes it
Adults · Children
Adult dose
As ranitidine, administer 150 mg orally twice daily, in the morning and at bedtime. Gastric and duodenal ulcers: Administer 150 mg orally twice daily or 300 mg once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 300 mg twice daily, in the morning and at bedtime. The same dosage and administration apply to combination therapy to treat ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) or to prevent gastric and duodenal ulcers during long-term NSAID use. These conditions usually heal within 4 weeks; conditions caused by NSAID use usually heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 150 mg once daily at bedtime as maintenance therapy. Gastroesophageal reflux disease: Administer 150 mg twice daily or 300 mg once daily at bedtime for 8 weeks. The dose may be increased to 150 mg four times daily in patients with severe gastroesophageal reflux disease. Zollinger-Ellison syndrome: Initiate treatment with 150 mg three times daily; the dose may be increased as needed. For severe disease, up to 6 g daily may be administered as directed by a physician. For upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, or acute gastric mucosal lesions, treatment is usually initiated with an injection. Once oral administration is possible, switch to oral administration and give 150 mg twice daily. Preanesthetic medication (prevention of Mendelson syndrome): Administer 150 mg 2 hours before induction of anesthesia. It is preferable to also administer 150 mg on the evening before surgery. Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbations of chronic gastritis: Administer 150 mg once daily at bedtime. Excess stomach acid, heartburn, and acid regurgitation: In patients 12 years of age and older, administer 75 mg orally twice daily (liquid formulation only). For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the plasma concentration of the drug, so readjust the dosing schedule immediately after hemodialysis. Adjust the dose as appropriate according to age and symptoms.
Child dose
Ages 8–18: 150 mg (2 mg/kg) per dose may be administered up to twice daily.

Ingredients

Manufacturer
Highple Life Sciences Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (such as ulcers), improvement of gastric mucosal lesions, and prevention of Mendelson's syndrome

  • Gastric and duodenal ulcers
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson syndrome
  • post-operative ulcers
  • gastric and duodenal ulcers due to NSAID administration
  • gastric mucosal lesions
  • erosion
  • bleeding
  • erythema
  • swelling
  • acute gastritis
View approved original text

This medication is used to treat gastrointestinal ulcer diseases such as gastric ulcers, duodenal ulcers, and gastroesophageal reflux disease. It is also effective in conditions caused by excessive gastric acid, such as Zollinger-Ellison syndrome, and helps prevent ulcers post-surgery and treat gastric and duodenal ulcers due to NSAID use. It is also used to improve gastric mucosal damage resulting from acute and chronic gastritis and upper gastrointestinal bleeding. It effectively alleviates symptoms of heartburn and acid regurgitation due to excessive gastric acid. This medication comprehensively addresses complex gastric issues to improve patient symptoms.

How to take

Adult dose

As ranitidine, administer 150 mg orally twice daily, in the morning and at bedtime. Gastric and duodenal ulcers: Administer 150 mg orally twice daily or 300 mg once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 300 mg twice daily, in the morning and at bedtime. The same dosage and administration apply to combination therapy to treat ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) or to prevent gastric and duodenal ulcers during long-term NSAID use. These conditions usually heal within 4 weeks; conditions caused by NSAID use usually heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 150 mg once daily at bedtime as maintenance therapy. Gastroesophageal reflux disease: Administer 150 mg twice daily or 300 mg once daily at bedtime for 8 weeks. The dose may be increased to 150 mg four times daily in patients with severe gastroesophageal reflux disease. Zollinger-Ellison syndrome: Initiate treatment with 150 mg three times daily; the dose may be increased as needed. For severe disease, up to 6 g daily may be administered as directed by a physician. For upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, or acute gastric mucosal lesions, treatment is usually initiated with an injection. Once oral administration is possible, switch to oral administration and give 150 mg twice daily. Preanesthetic medication (prevention of Mendelson syndrome): Administer 150 mg 2 hours before induction of anesthesia. It is preferable to also administer 150 mg on the evening before surgery. Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbations of chronic gastritis: Administer 150 mg once daily at bedtime. Excess stomach acid, heartburn, and acid regurgitation: In patients 12 years of age and older, administer 75 mg orally twice daily (liquid formulation only). For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the plasma concentration of the drug, so readjust the dosing schedule immediately after hemodialysis. Adjust the dose as appropriate according to age and symptoms.

Child dose

Ages 8–18: 150 mg (2 mg/kg) per dose may be administered up to twice daily.

Precautions

This medication should not be used in patients with hypersensitivity to its components. It should not be administered to patients with a history of acute porphyria, as it may provoke seizures. Patients with genetic issues such as galactose intolerance, lactase deficiency, or glucose-galactose malabsorption should not take this medication. Patients with impaired renal function may require dosage adjustments as it is excreted through the kidneys, which could lead to increased plasma concentrations. Patients with liver dysfunction should take this medication with caution. Past experiences of drug hypersensitivity and elderly patients should also be treated carefully. In cases where this medication is taken with nonsteroidal anti-inflammatory drugs (NSAIDs), elderly patients or those with a history of digestive ulcers require regular monitoring. It may obscure symptoms of gastric cancer, therefore, patients with gastric ulcers or those who are middle-aged or older and have experienced recent or changing dyspeptic symptoms should confirm malignancy before taking. Patients with Helicobacter pylori-positive gastric and duodenal ulcers require bacterial eradication treatment. This medication can rarely cause hypersensitivity reactions such as anaphylactic shock, hives, and angioedema, so if any unusual symptoms occur, usage must be stopped immediately. Various side effects could occur, such as blood abnormalities, liver dysfunction, heart rhythm disorders, gastrointestinal symptoms, and neurological issues, so patients should consult healthcare professionals if symptoms arise. Particularly, patients with impaired renal function, the elderly, and severely ill patients may present neurological symptoms such as confusion or seizures, so caution is warranted. The medication should be used at the minimal effective dose while monitoring therapeutic effects, and alternative treatments should be considered if no efficacy is observed. Elderly patients, chronic pulmonary disease patients, diabetic patients, and those with weakened immunity may have an increased risk of pneumonia, thus they should be cautious. If dizziness or drowsiness occurs, driving or operating dangerous machinery should be avoided. This medication may interact with other drugs, particularly anticoagulants, thus the coagulation state should be closely monitored. When taken with sucralfate, absorption may be decreased, so they should be taken at least 2 hours apart. Women who are pregnant or may become pregnant should take this medication only when its benefits outweigh the risks, and caution is also advised when breastfeeding. The safety in children has not been adequately established. Elderly patients may experience increased plasma concentrations due to renal function decline, hence dosage and administration intervals should be adjusted. In cases of overdose, special problems are rare; however, appropriate measures such as vomiting or gastric lavage should be taken, and if necessary, blood dialysis can be performed to eliminate the drug. This medication should be stored out of reach of children, and transferring it to other containers is not advisable for quality maintenance and safety.

Side effects

  • Anaphylactic shock
  • urticaria
  • angioedema
  • rash
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • elevated serum creatinine levels
Show 56 more
  • leukopenia
  • thrombocytopenia
  • myelosuppression
  • aplastic anemia
  • hypoplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • general malaise
  • weakness
  • subcutaneous and mucosal hemorrhage
  • fever
  • hepatic dysfunction
  • jaundice
  • hepatitis
  • bradycardia
  • atrioventricular block
  • tachycardia
  • vasculitis
  • constipation
  • nausea
  • vomiting
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • diarrhea
  • acute pancreatitis
  • dizziness
  • drowsiness
  • convulsions
  • headache
  • heaviness in the head
  • insomnia
  • agitation
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • altered consciousness
  • hepatic myoclonus
  • gynecomastia
  • galactorrhea
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • glossitis
  • pruritus
  • mucosal pemphigoid syndrome
  • toxic epidermal necrolysis
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it must be stored in a special container that prevents light exposure. Additionally, the medication should be stored at room temperature between 1 and 30 degrees Celsius. This way, the effectiveness of the medication can be preserved for a longer time.

Appearance and packaging

Appearance

Cream to pale yellow round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.